Advertisement
Liquidia Corporation

Liquidia Corporation (LQDA) Stock Overview

Explore Liquidia Corporation’s financial performance, market position, analyst ratings, and future outlook.

LQDANASDAQ
HealthcareBiotechnology
$77.75
$1.26(1.65%)
U.S. Market opens in 16h 11m
Advertisement

Liquidia Corporation (LQDA)

Meyka AI Score

Z

Key Financials

Market Cap6.9B
P/E Ratio320.87
EPS (TTM)$0.14
ROE0.47%
Fundamental Analysis

AI Price Forecasts

1 Month$87.64
3 Months$77.44
1 Year Target$69.51

LQDA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Liquidia Corporation (LQDA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.32, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $69.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 320.87 and a market capitalization of 6.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.65%
5-Day Change
-3.52%
1-Month Change
8.29%
3-Month Change
93.79%
6-Month Change
100.44%
Year-to-Date (YTD) Change
125.43%
1-Year Change
435.84%
3-Year Change
905.82%
5-Year Change
2913.57%
All-Time (Max) Change
600.45%

Contact Information

919 328 4400
419 Davis Drive, Morrisville, NC, 27560

Company Facts

2,160 Employees
IPO DateJul 26, 2018
CountryUS
Actively Trading

Frequently Asked Questions